Breast Cancer Res Treat
-
Publication Venue For
- Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy.. 143:531-539. 2014
- Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.. 139:607-616. 2013
- Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice.. 133:301-310. 2012
- Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients.. 130:255-266. 2011
- What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?. 130:691-697. 2011
- The benefits of discussing adjuvant therapies one at a time instead of all at once.. 129:79-87. 2011
- Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer.. 127:511-520. 2011
- Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.. 124:441-451. 2010
- Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer.. 122:135-144. 2010
- Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer.. 121:771-776. 2010
- Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.. 119:613-620. 2010
- Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.. 118:635-643. 2009
- Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells.. 118:197-205. 2009
- Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).. 113:479-490. 2009
- Are all aromatase inhibitors alike?. 112 Suppl 1:35-43. 2008